For: | Marcelin JR, Beam E, Razonable RR. Cytomegalovirus infection in liver transplant recipients: Updates on clinical management. World J Gastroenterol 2014; 20(31): 10658-10667 [PMID: 25152570 DOI: 10.3748/wjg.v20.i31.10658] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i31/10658.htm |
Number | Citing Articles |
1 |
Emanuele Nicastro, Lorenzo D’Antiga. Pediatric Hepatology and Liver Transplantation. 2019; : 593 doi: 10.1007/978-3-319-96400-3_34
|
2 |
Jassin Rashidi‐Alavijeh, Jens Christoph Crämer, Helena Louisa Sauter, Katharina Willuweit, Katja Straub, Heiner Wedemeyer, Kerstin Herzer. Primary sclerosing cholangitis as an independent risk factor for cytomegalovirus infection after liver transplant. Transplant Infectious Disease 2021; 23(3) doi: 10.1111/tid.13553
|
3 |
Nurettin Dogan, Anna Hüsing-Kabar, Hartmut H. Schmidt, Vito R. Cicinnati, Susanne Beckebaum, Iyad Kabar. Acute allograft rejection in liver transplant recipients: Incidence, risk factors, treatment success, and impact on graft failure. Journal of International Medical Research 2018; 46(9): 3979 doi: 10.1177/0300060518785543
|
4 |
Hannah Nam, Kathy M. Nilles, Josh Levitsky, Michael G. Ison. Donor-derived Viral Infections in Liver Transplantation. Transplantation 2018; 102(11): 1824 doi: 10.1097/TP.0000000000002326
|
5 |
Kristen G. Valencia Deray, Kathleen E. Hosek, Divya Chilukuri, Jordan R. Dunson, David R. Spielberg, Sarah J. Swartz, Joseph A. Spinner, Daniel H. Leung, Elizabeth A. Moulton, Flor M. Munoz, Gail J. Demmler-Harrison, Claire E. Bocchini. Epidemiology and long-term outcomes of cytomegalovirus DNAemia and disease in pediatric solid organ transplant recipients. American Journal of Transplantation 2022; 22(1): 187 doi: 10.1111/ajt.16822
|
6 |
Norrapat Onpoaree, Anapat Sanpavat, Palittiya Sintusek. Cytomegalovirus infection in liver-transplanted children. World Journal of Hepatology 2022; 14(2): 338-353 doi: 10.4254/wjh.v14.i2.338
|
7 |
Hanna L. Kleiboeker, Margaret R. Jorgenson, Glen E. Leverson, John P. Rice, Christopher M. Saddler, Jeannina A. Smith, David Al‐Adra. Risk factors for high level cytomegalovirus viremia in liver transplant recipients and associated outcomes. Transplant Infectious Disease 2022; 24(4) doi: 10.1111/tid.13898
|
8 |
Venancio Avancini Ferreira Alves. Practical Hepatic Pathology: a Diagnostic Approach. 2018; : 191 doi: 10.1016/B978-0-323-42873-6.00013-5
|
9 |
Andrew D. Clouston, Stefan G. Hübscher. MacSween's Pathology of the Liver. 2024; : 947 doi: 10.1016/B978-0-7020-8228-3.00014-4
|
10 |
P. Czarnecka, K. Czarnecka, O. Tronina, M. Durlik. Cytomegalovirus Disease After Liver Transplant—A Description of a Treatment-Resistant Case: A Case Report and Literature Review. Transplantation Proceedings 2018; 50(10): 4015 doi: 10.1016/j.transproceed.2018.05.014
|
11 |
Diagnostic Pathology: Hepatobiliary and Pancreas. 2017; : 72 doi: 10.1016/B978-0-323-44307-4.50029-4
|
12 |
Venancio Avancini Ferreira Alves. Acute Viral Hepatitis: Beyond A, B, and C. Surgical Pathology Clinics 2018; 11(2): 251 doi: 10.1016/j.path.2018.02.014
|
13 |
|
14 |
Karen C. Tsai, Lara A. Danziger-Isakov, David B. Banach. Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients: a Focus on Prevention. Current Infectious Disease Reports 2016; 18(2) doi: 10.1007/s11908-015-0511-8
|
15 |
Margaret R. Jorgenson, Jillian L. Descourouez, Glen E. Leverson, Erin K. McCreary, Michael R. Lucey, Jeannina A. Smith, Robert R. Redfield. High-Dose Acyclovir for Cytomegalovirus Prophylaxis in Seropositive Abdominal Transplant Recipients. Annals of Pharmacotherapy 2018; 52(1): 5 doi: 10.1177/1060028017728296
|
16 |
Andrew D. Clouston, Stefan G. Hübscher. Macsween's Pathology of the Liver. 2018; : 880 doi: 10.1016/B978-0-7020-6697-9.00014-5
|
17 |
Cornelius Engelmann, Martina Sterneck, Karl Heinz Weiss, Silke Templin, Steffen Zopf, Gerald Denk, Dennis Eurich, Johann Pratschke, Johannes Weiss, Felix Braun, Martin-Walter Welker, Tim Zimmermann, Petra Knipper, Dirk Nierhoff, Thomas Lorf, Elmar Jäckel, Hans-Michael Hau, Tung Yu Tsui, Aristoteles Perrakis, Hans-Jürgen Schlitt, Kerstin Herzer, Frank Tacke. Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers. Journal of Clinical Medicine 2020; 9(8): 2352 doi: 10.3390/jcm9082352
|
18 |
Ekta Gupta, Viniyendra Pamecha, Yogita Verma, Niteen Kumar, Archana Rastogi, Nadeem Hasnian, Ajeet Singh Bhadoria. Pre-Transplant Cytomegalovirus Immunoglobulin G Antibody Levels Could Prevent Severe Cytomegalovirus Infections Post-Transplant in Liver Transplant Recipients: Experience from a Tertiary Care Liver Centre. Indian Journal of Medical Microbiology 2017; 35(4): 499 doi: 10.4103/ijmm.IJMM_17_201
|
19 |
Yoshitomo Morinaga, Yasushi Sawayama, Masaaki Hidaka, Sayaka Mori, Jun Taguchi, Mitsuhisa Takatsuki, Susumu Eguchi, Yasushi Miyazaki, Katsunori Yanagihara. Diagnostic Utility of Cytomegalovirus Nucleic Acid Testing during Antigenemia-Guided Cytomegalovirus Monitoring after Hematopoietic Stem Cell Transplantation or Liver Transplantation. The Tohoku Journal of Experimental Medicine 2019; 247(3): 179 doi: 10.1620/tjem.247.179
|
20 |
|
21 |
Jong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh, Young Eun Ha, Dong Hyun Sinn, Gyu-Seong Choi, Kyong Ran Peck, Suk-Koo Lee, Kwan Man. Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients. PLOS ONE 2015; 10(5): e0123554 doi: 10.1371/journal.pone.0123554
|
22 |
Manasvi Gupta, Gaurav Manek, Kaitlyn Dombrowski, Rakhi Maiwall. Newer developments in viral hepatitis: Looking beyond hepatotropic viruses. World Journal of Meta-Analysis 2021; 9(6): 522-542 doi: 10.13105/wjma.v9.i6.522
|
23 |
Lydia Sastre, Raquel García, Julián-Gonzalo Gándara, Pablo Ruiz, Julissa Lombardo, Jordi Colmenero, Miquel Navasa, Gonzalo Crespo. Incidence, Predictors, and Impact on Survival of Long-term Cardiovascular Events After Liver Transplantation. Transplantation 2020; 104(2): 317 doi: 10.1097/TP.0000000000002852
|
24 |
B. Sharmila Mohanraj, Amol S. Rangnekar, Joseph G. Timpone. Principles and Practice of Transplant Infectious Diseases. 2019; : 41 doi: 10.1007/978-1-4939-9034-4_3
|
25 |
D. Topalis, S. Gillemot, R. Snoeck, G. Andrei. Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymerase. Nucleic Acids Research 2016; : gkw875 doi: 10.1093/nar/gkw875
|
26 |
Annalisa Boscolo, Eugenia Menin, Beatrice Zelaschi, Laura Albertoni, Giacomo Zanus, Fabio Baratto. Early Use of Etanercept for Graft-Versus-Host Disease After Liver Transplant: the Importance of Broad Spectrum Infective Prophylaxis. Experimental and Clinical Transplantation 2020; 18(1): 123 doi: 10.6002/ect.2017.0231
|
27 |
S. Ciesek, H. Wedemeyer. Virale Infektionen bei Lebertransplantierten. Der Gastroenterologe 2020; 15(3): 227 doi: 10.1007/s11377-020-00434-x
|
28 |
Andy Roemhild, Petra Reinke. Virus-specific T-cell therapy in solid organ transplantation. Transplant International 2016; 29(5): 515 doi: 10.1111/tri.12659
|
29 |
Yoshinori Harada, Masaki Iwai. Diagnosis of Liver Disease. 2019; : 35 doi: 10.1007/978-981-13-6806-6_3
|
30 |
Chalermrat Bunchorntavakul, K. Rajender Reddy. Epstein-Barr Virus and Cytomegalovirus Infections of the Liver. Gastroenterology Clinics of North America 2020; 49(2): 331 doi: 10.1016/j.gtc.2020.01.008
|
31 |
Anne M. Larson, George B. McDonald. Transplant Infections. 2016; : 653 doi: 10.1007/978-3-319-28797-3_36
|
32 |
James M. Neuberger, Wolf O. Bechstein, Dirk R.J. Kuypers, Patrizia Burra, Franco Citterio, Sabina De Geest, Christophe Duvoux, Alan G. Jardine, Nassim Kamar, Bernhard K. Krämer, Herold J. Metselaar, Frederik Nevens, Jacques Pirenne, Manuel L. Rodríguez-Perálvarez, Didier Samuel, Stefan Schneeberger, Daniel Serón, Pavel Trunečka, Giuseppe Tisone, Teun van Gelder. Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients. Transplantation 2017; 101(4S): S1 doi: 10.1097/TP.0000000000001651
|
33 |
Monika Lindemann, Benjamin Wilde, Justa Friebus-Kardash, Anja Gäckler, Oliver Witzke, Ulf Dittmer, Peter A. Horn, Andreas Kribben, Nils Mülling, Ute Eisenberger. Comparison of Humoral and Cellular CMV Immunity in Patients Awaiting Kidney Transplantation. Diagnostics 2021; 11(9): 1688 doi: 10.3390/diagnostics11091688
|
34 |
Sandra Ciesek, Heiner Wedemeyer. Virale Infektionen bei Lebertransplantierten. Wiener klinisches Magazin 2020; 23(5): 240 doi: 10.1007/s00740-020-00352-2
|
35 |
Xiao Wang, Yanqun Xu, Dorothy E. Scott, Haruhiko Murata, Evi B. Struble. Binding and neutralizing anti-cytomegalovirus activities in immune globulin products. Biologicals 2017; 50: 35 doi: 10.1016/j.biologicals.2017.09.004
|
36 |
Shunji Nagai, Richard S. Mangus, Eve Anderson, Burcin Ekser, Chandrashekhar A. Kubal, Jonathan A. Fridell, A. Joseph Tector. Cytomegalovirus Infection After Intestinal/Multivisceral Transplantation. Transplantation 2016; 100(2): 451 doi: 10.1097/TP.0000000000000832
|
37 |
Smaranda Gliga, Melanie Fiedler, Theresa Dornieden, Anne Achterfeld, Andreas Paul, Peter A. Horn, Kerstin Herzer, Monika Lindemann. Comparison of Three Cellular Assays to Predict the Course of CMV Infection in Liver Transplant Recipients. Vaccines 2021; 9(2): 88 doi: 10.3390/vaccines9020088
|
38 |
Munehiro Furuichi, Takeo Fujiwara, Akinari Fukuda, Mureo Kasahara, Isao Miyairi. Fulminant Hepatic Failure as a Risk Factor for Cytomegalovirus Infection in Children Receiving Preemptive Therapy After Living Donor Liver Transplantation. Transplantation 2016; 100(11): 2404 doi: 10.1097/TP.0000000000001435
|
39 |
Irmeli Lautenschlager, Raisa Loginov, Heikki Mäkisalo, Krister Höckerstedt. Prospective long-term study on primary CMV infections in adult liver transplant (D+/R−) patients after valganciclovir prophylaxis. Journal of Clinical Virology 2015; 71: 73 doi: 10.1016/j.jcv.2015.08.009
|
40 |
Nopparak Chanburanavah, Sophida Boonsathorn, Nopporn Apiwattanakul, Chatmanee Lertudomphonwanit, Songpon Getsuwan, Pornthep Tanpowpong, Suporn Treepongkaruna. Risk factors of cytomegalovirus infection after pediatric liver transplantation and effectiveness of preemptive therapy. Transplant Infectious Disease 2023; 25(3) doi: 10.1111/tid.14057
|
41 |
Rayan El Sibai, Sari R. Freedman, J. David Gatz. A Narrative Review of the Evaluation and Management of Liver Transplant Complications in the Emergency Department. The Journal of Emergency Medicine 2023; 64(5): 596 doi: 10.1016/j.jemermed.2023.02.022
|
42 |
Emanuele Nicastro, Sara Giovannozzi, Paola Stroppa, Valeria Casotti, Anna Paola Callegaro, Alessandra Tebaldi, Claudio Farina, Michele Colledan, Lorenzo D'Antiga. Effectiveness of Preemptive Therapy for Cytomegalovirus Disease in Pediatric Liver Transplantation. Transplantation 2017; 101(4): 804 doi: 10.1097/TP.0000000000001531
|
43 |
RyungA Kang, Sangbin Han, Jong Man Kim, Kyo Won Lee, Hyo Won Park, Joong Hyun Ahn, Seonwoo Kim, Eun‐Suk Kang, Gaab Soo Kim, Jae‐Won Joh. Postoperative hyperglycemia may negatively impact cytomegalovirus infection in seropositive liver transplant recipients: a retrospective cohort study. Transplant International 2020; 33(1): 68 doi: 10.1111/tri.13496
|
44 |
Priya Walabh, David P. Moore, Graham Paget, Anja Meyer, Porai Nthabaleng M. Moshesh, Pravina Walabh, Sechaba T. Palweni, Christina Hajinicolaou. Healthcare disparity and its associations with cytomegalovirus disease in pediatric liver transplant recipients in South Africa. Transplant Infectious Disease 2022; 24(6) doi: 10.1111/tid.13917
|
45 |
Marian G. Michaels, Atul Humar. Cytomegalovirus in the Pediatric Transplant Recipient. Transplantation 2017; 101(4): 686 doi: 10.1097/TP.0000000000001627
|
46 |
Michael Barry. Single-cycle adenovirus vectors in the current vaccine landscape. Expert Review of Vaccines 2018; : 1 doi: 10.1080/14760584.2018.1419067
|
47 |
Magdalena Siodlak, Margaret R. Jorgenson, Jillian L. Descourouez, Glen E. Leverson, Didier A. Mandelbrot, Jeannina A. Smith, Robert R. Redfield. Impact of High‐Dose Acyclovir Cytomegalovirus Prophylaxis Failure in Abdominal Solid Organ Transplant Recipients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2018; 38(7): 694 doi: 10.1002/phar.2126
|
48 |
William J. Britt, Mark N. Prichard. New therapies for human cytomegalovirus infections. Antiviral Research 2018; 159: 153 doi: 10.1016/j.antiviral.2018.09.003
|